EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Optimizing Use of Real‐World Data in Regulatory Decision Making for Medical Devices Used in Surgical Procedures

Guy Cafri iD, Florence Bourgeois iD, Paul Coplan iD

Pharmacoepidemiology and Drug Safety · 2026-06 · 35 (6)

DOI: 10.1002/pds.70407 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmacoepidemiology and Drug Safety, online erschienen am 07.06.2026. Verfasst von Guy Cafri und 2 weiteren Autor:innen. Beteiligte Einrichtung: Epidemiology and Real-World Data Sciences, Johnson & Johnson MedTech, Office of the Chief Medical Officer, New Brunswick, New Jersey, USA. Hauptthemen laut MEDLINE: Device Approval, Decision Making, Surgical Equipment, Equipment and Supplies. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

In the United States, the Food and Drug Administration has provided guidance on the contexts in which real‐world evidence (RWE) can be used to support regulatory decisions for medical devices.

Methods

In this paper, we review different sources of real‐world data (RWD) for medical devices used in surgical procedures and how to optimize the design and analysis features of RWD studies to maximize the strength of RWE. The design and analysis of a study are critical to ensuring that the RWE generated from the RWD can ultimately be used to support a regulatory decision or fulfill a commitment for a medical device. We consider several topics relevant to medical device RWE in our review: misclassification and measurement error, causal inference, and incomplete follow‐up.

Results

Some key challenges include indication and outcome misclassification in non‑registry data, tenuous assumptions of single‑arm designs, device‑ and surgeon‑level confounding in comparative studies, and potentially informative loss to follow‑up from censoring (e.g., insurance termination).

Conclusion

The review is intended as a guide to researchers and regulators interested in generating or evaluating medical device RWE for regulatory purposes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Device ApprovalDecision MakingSurgical EquipmentEquipment and SuppliesMedical Device LegislationHumansUnited States Food and Drug AdministrationUnited StatesResearch Design

Autor:innen und Institutionen

  • Epidemiology and Real-World Data Sciences, Johnson & Johnson MedTech, Office of the Chief Medical Officer, New Brunswick, New Jersey, USA.
  • Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
  • Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Guy Cafri, Florence Bourgeois, Paul Coplan

Zitieren

APA

Cafri, G., Bourgeois, F., & Coplan, P. (2026). Optimizing Use of Real‐World Data in Regulatory Decision Making for Medical Devices Used in Surgical Procedures. Pharmacoepidemiology and Drug Safety, 35(6). https://doi.org/10.1002/pds.70407

Vancouver

Cafri G, Bourgeois F, Coplan P. Optimizing Use of Real‐World Data in Regulatory Decision Making for Medical Devices Used in Surgical Procedures. Pharmacoepidemiology and Drug Safety. 2026;35(6). doi:10.1002/pds.70407

BibTeX
@article{Cafri2026,
  author = {Cafri, Guy and Bourgeois, Florence and Coplan, Paul},
  title = {Optimizing Use of Real‐World Data in Regulatory Decision Making for Medical Devices Used in Surgical Procedures},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2026},
  volume = {35},
  number = {6},
  doi = {10.1002/pds.70407}
}
Kostenlos starten →